(Q28212423)

2

0 references

W H Wang

3

0 references

J D Wang

4

0 references

W M Wong

5

0 references

A O O Chan

6

0 references

M F Yuen

7

0 references

S K Lam

8

0 references

H K-L Cheung

9

0 references

X G Liu

10

0 references

B C-Y Wong

Alimentary Pharmacology & Therapeutics

11

0 references

language of work or name

English

0 references

publication date

15 September 2004

0 references

published in

0 references

volume

20

0 references

issue

6

0 references

page(s)

675-81

0 references

cites work

Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02168.X

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02168.X

Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02168.X

Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02168.X

Upregulated cyclooxygenase-2 inhibits apoptosis of human gastric epithelial cells infected with Helicobacter pylori

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Helicobacter pylori-negative duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Chemoprevention of gastric cancer by celecoxib in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X

Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02168.X